MediWound announces promising early results from its latest wound healing technology trial, sparking investor interest. The company's stock shows a slight uptick following the positive news.
MediWound is a biotechnology company focused on developing advanced solutions for wound care.
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing